Skip to main content

Advertisement

SpringerLink
Log in

Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Matrix metalloproteinases (MMPs) are known to play an important role in extracellular matrix remodeling during the process of tumor invasion and metastasis. However, little is known about their role in preinvasive lesions and early esophageal carcinomas.

Method

Immunohistochemical analysis of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) expression was carried out in paraffin-embedded sections of surgically resected esophageal squamous cell carcinoma (ESCC) (58 cases) and paired distal normal esophageal tissues (44 cases) and correlated with clinicopathological parameters.

Result

Overexpression of MMP-2 and MMP-9 proteins was observed in 39 (67%) and 32 (55%) of the 58 ESCCs, respectively localized in tumor cell cytoplasm and stromal elements. Histological evaluation of hematoxylin- and eosin-stained 44 matched distal normal esophageal tissue sections revealed that 26 comprised of normal epithelium, while 15 tissues showed evidence of dysplasia and three tissues showed hyperplasia. Interestingly, 12 (80%) and 13 (87%) of these 15 dysplasias showed immunostaining for MMP-2 and MMP-9 proteins, respectively. Low levels of MMP-2 and MMP-9 were observed in 10 (38%) and 6 (23%) of 26 matched histologically normal esophageal tissues, respectively. Higher MMP-2 immunopositivity was observed in well and moderately differentiated SCCs in comparison with poorly differentiated tumors. The expression of MMP-2 was significantly reduced with the progressive de-differentiation of esophageal SCCs (P =0.03). Overexpression of MMP-2 and MMP-9 in dysplasia as well as SCC suggests that these alterations occur in early stages of esophageal tumorigenesis.

Conclusion

Increased levels of MMP-2 and MMP-9 proteins in ESCCs as compared to normal esophageal tissues suggest their association with esophageal tumorigenesis. Increased levels of these MMPs are observed in majority of dysplasias analyzed herein, indicating that these alterations may be early events in esophageal tumorigenesis. In-depth studies are warranted to determine their role in development and progression of esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a–l
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Basset P, Okada A, Chenard MP, Kannan R, Stoll I, Anglard P, Bellocq JP, Rio MC (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression therapeutical implications. Matrix Biol 15:535–541

    Article  CAS  PubMed  Google Scholar 

  2. Chambers AF, Matrisian LM (1997) Changing view of the role of matrix metalloproteinases in metastasis. J Natl. Cancer Inst 89:1260–1270

    Article  CAS  Google Scholar 

  3. Chen PS, Zhai WR, Zhou XM, Zhang JS, Zhang YE, Ling YQ, Gu YH (2001) Effects of hypoxia, hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells. World J Gastroenterol 7:647–651

    CAS  PubMed  Google Scholar 

  4. Colby TV, Bennett W, Harris CC, Stetler-Stevenson WG, Liotta L, Ferrans VJ, Travis WD (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. Hum Pathol 31:296–305

    PubMed  Google Scholar 

  5. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, HAnby A, Balkwill F (1993) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53:5365–5369

    CAS  PubMed  Google Scholar 

  6. Dong Z, Kumar R, Yang X, Fidller IJ (1997) Macrophage derived metalloelastase is responsible for generation of angiostatin in Lewis lung carcinoma. Cell 88:801–810

    CAS  PubMed  Google Scholar 

  7. Galateau-Salle FB, Luna RE, Horiba K, Sheppard MN, Hayashi T, Fleming MV, Colby TV, Bennett W, Harris CC, Stetler-Stevenson WG, Liotta L, Ferrans VJ, Travis WD (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. Hum Pathol 3:296–305

    Google Scholar 

  8. Hart IR, Saini A (1992) Biology of tumour metastasis. Lancet 339:1453–1457

    CAS  PubMed  Google Scholar 

  9. Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ (2000) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115:337–344

    PubMed  Google Scholar 

  10. Johnsen M, Lund LR, Romer J, Almholt K, Dano K (1998) Cancer invasion and tissues remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10:667–671

    Article  CAS  PubMed  Google Scholar 

  11. Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55:1856–1862

    CAS  PubMed  Google Scholar 

  12. Koyama H, Iwata H, Kuwabara Y, Iwase H, Kobayashi S, Fuji Y (2000) Gelatinolytic activity of matrix metalloproteinase-2 and −9 in oesophageal carcinoma; a study using in situ zymography. Eur J Cancer 36:2164–2170

    Article  CAS  PubMed  Google Scholar 

  13. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clin 49:8–31

    CAS  PubMed  Google Scholar 

  14. Lijnen HR, Ugwu F, Bini A, Collen D (1998) Generation of angiostatin-like fragment from plasminogen by stromelysin-1. Biochemistry 37:4699–4702

    Article  CAS  PubMed  Google Scholar 

  15. Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE (1998) Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43:791–797

    CAS  PubMed  Google Scholar 

  16. Naylor MS, Stamp GW, Davies BD, Balkwill FR (1994) Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 58:50–56

    CAS  PubMed  Google Scholar 

  17. O-Cheroenrat P, Rhys-Evans PH, Eccles SA (2001) Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127:813–820

    CAS  PubMed  Google Scholar 

  18. Ohashi K, Nemoto T, Nakamura K, Nemori R (2000) Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 88:2201–2209

    CAS  PubMed  Google Scholar 

  19. Patterson BC, Sang QA (1997) Angiostatin conveting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272:28823–28825

    Article  CAS  PubMed  Google Scholar 

  20. Remade AG, Neol A, Duggan C, McDermott E, Higgins NO, Foidart JM, Duffy MJ (1998) Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer 77:926–931

    PubMed  Google Scholar 

  21. Sato F, Shimada Y, Watanabe G, Uchida S, Makino T, Imamura M (1999) Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer. Br J Cancer 80:1366–1372

    Article  CAS  PubMed  Google Scholar 

  22. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T, Morimatsu M (1992) Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 70:2747–2753

    CAS  PubMed  Google Scholar 

  23. Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, Makino T, Kano M (1999) Prognostic factors of esophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 80:1281–1288

    Article  CAS  PubMed  Google Scholar 

  24. Sobin LH, Flemming ID (1997) TNM classification of malignant tumors, 5th edn. Union Internationale Centre le cancer and the American Joint Committee on Cancer. Cancer 80:1803–1804

    CAS  PubMed  Google Scholar 

  25. Sternlicht MD, Lotcher A, Sympson CJ, Huey B, rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z (1999) The stomal proteinase MMP3/Stromelysin-1 promotes mammary carcinogenesis. Cell 98:137–146

    PubMed  Google Scholar 

  26. Stetler-Stevenson WG, Liotta LA, Kliener DE (1993) Extracellular Matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434–1441

    CAS  PubMed  Google Scholar 

  27. Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T (1998) Expression of matrix metalloproteinases (MMP-1 and −2) and their inhibitors (TIMP-1, -2 and −3) in oral lichen planus, dysplasia, squamous cell carcinoma, and lymph node metastasis. Br J Cancer 77:2239–2245

    CAS  PubMed  Google Scholar 

  28. Suzuki T, Kuwabara Y, Iwata H, Mitani M, Shinoda N, Sato A, Mitsui A, Sugiura M, Kato J, Fujii Y (2001) Role of matrix metalloproteinase-9 in in vitro invasion of esophageal carcinoma cells. J Surg Oncol 81:80–86

    Article  Google Scholar 

  29. Talvensaari A, Apaja-Saekkinen M, Hoyhtya M, Westerlund A, Puistola U, Turpeenniemi T (1999) Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation. Gynecol Oncol 72:306–311

    Article  CAS  PubMed  Google Scholar 

  30. Tryggvason K, Hoyhta M, Pyke M (1993) Type IV collagenases in invasive tumors. Breast Cancer Res Treat 24:209–218

    CAS  PubMed  Google Scholar 

  31. Uria JA, Lopez-Otin C (2000) Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 60:4745–4751

    CAS  PubMed  Google Scholar 

  32. Visscher DW, Hoyhtya M, Ottosen SK, Liang CM, Sarkar FH, Crissman JD, Fridman R (1994) Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59:339–344

    CAS  PubMed  Google Scholar 

  33. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, Arimura Y, Endo T, Hinoda Y, Hosokawa M, Imai K (1999) Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59:3313–3316

    CAS  PubMed  Google Scholar 

  34. Yamashita K, Mori M, Kataoka A, Inoue H, Sugimachi K (2001) The clinical significance of MMP-1 expression in oesophageal carcinoma. Br J Cancer 84:276–282

    Article  CAS  PubMed  Google Scholar 

  35. Yu Q, Stamenkovic I (2000) Cell surface localized matrix metalloproteinase-9 proteolytically activatesTGF-β and promotes tumor invasion and angiogenesis. Genes Dev 15:163–176

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, All India Institute of Medical Sciences, 110029, New Delhi, Ansari Nagar, India

    S. Samantaray, R. Sharma & R. Ralhan

  2. Department of Gastrointestinal Surgery, All India Institute of Medical Sciences, New Delhi, Ansari Nagar, India

    T. K. Chattopadhyaya

  3. Department of Pathology, All India Institute of Medical Sciences, New Delhi, Ansari Nagar, India

    S. Datta Gupta

Authors
  1. S. Samantaray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. K. Chattopadhyaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Datta Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Ralhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Ralhan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Samantaray, S., Sharma, R., Chattopadhyaya, T.K. et al. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.. J Cancer Res Clin Oncol 130, 37–44 (2004). https://doi.org/10.1007/s00432-003-0500-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-003-0500-4

Keywords

Search

Navigation